

Cover Story
FreeNews Analysis
By Matthew Bin Han Ong
Now that Joseph R. Biden Jr. is inaugurated and safely ensconced in the White House, cancer groups expect him to pick up where he left off as vice president four years ago—pursuing a sober and ambitious agenda for accelerating progress in cancer research.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Oncofertility has been an overlooked standard of care—now states are taking action
- Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned














